Clinical Trial Update: Measurement of Relaxin Peptide in Multiple Sclerosis (MS)

View source ↗

Summary

A clinical trial evaluating the measurement of relaxin peptide in relapsing-remitting multiple sclerosis has completed enrollment and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Snippet

Sponsor: Providence Health & Services | Conditions: Multiple Sclerosis, Relapsing-Remitting | Status: COMPLETED | Results posted: 2025-06-22